The first steps towards planning and realising the Innovation Centre for Medical Technology and Pharmaceuticals (IZMP) were taken on the initiative of the Free State of Bavaria, the city of Erlangen and the local savings bank in Erlangen (Sparkasse).

Within the framework of the High-Tech Offensive programme in Bavaria, the Free State of Bavaria has invested approximately 10 m euros in the Innovation Centre for Medical Technology and Pharmaceuticals in Erlangen (IZMP).The money stemmed from the proceeds of privatisation. The city of Erlangen is supporting the project and helped the financing of the project by providing the land in Henkestraße. A further €750,000 was provided by the Sparkasse Erlangen in the form of a loan to the Besitz- und Immobilienverwaltungsgesellschaft Innovationszentrum Medizintechnik und Pharma (BIVG – a holding and property company).

The BIVG is a private company with the LfA as sole shareholder. FABIAN Immobilien Management Gesellschaft generates business for the BIVG and thus takes on all the BIVG's task and responsibilities of running the company and managing the project.